Core Insights - Avicanna Inc. has successfully completed its first commercial export of CBG-dominant cannabis flower to Australia through its subsidiary Santa Marta Golden Hemp SAS (SMGH), marking a significant milestone in its international operations [1][5] Group 1: Export and Market Reach - The export to Australia represents the 21st market for SMGH and the 24th market for all Avicanna products, showcasing the company's expanding global footprint [1][5] - With this shipment, SMGH has now supplied products to 21 international markets, reflecting Avicanna's capability to navigate complex regulatory frameworks [5] Group 2: Operational Strengths - Over the past two years, Avicanna has invested in process development, infrastructure, and quality systems to align SMGH's operations with international regulatory expectations for active pharmaceutical ingredients (API) and raw materials [3] - SMGH's operational model includes year-round cultivation, controlled environmental parameters, and established genetic portfolios, which contribute to consistent production cycles and cost efficiencies essential for long-term participation in international medical cannabis markets [4] Group 3: Certifications and Production Capacity - SMGH has received Good Agricultural and Collection Practices (GACP) and Organic certifications under the USDA National Organic Program for its hemp cultivars, ensuring compliance with high-quality standards [8] - The SMGH facility encompasses approximately 300,000 square feet of cultivation space with an extraction capacity of 300 kg, yielding approximately 26,400 kg annually [8]